2018
Predicting non-melanoma skin cancer via a multi-parameterized artificial neural network
Roffman D, Hart G, Girardi M, Ko CJ, Deng J. Predicting non-melanoma skin cancer via a multi-parameterized artificial neural network. Scientific Reports 2018, 8: 1701. PMID: 29374196, PMCID: PMC5786038, DOI: 10.1038/s41598-018-19907-9.Peer-Reviewed Original ResearchConceptsNon-melanoma skin cancerFamily historySkin cancerUVR exposureHistory of strokePotential predictive parametersNon-cancer casesFamily history informationUltraviolet radiation exposureDiabetic statusSmoking statusHeart diseaseRisk factorsExercise habitsHispanic ethnicityPredictive parametersAdult survey dataEarly detectionRadiation exposureROC curveHealth informationPersonal health informationNovel associationsCancerExposure
2010
The contribution of Langerhans cells to cutaneous malignancy
Lewis J, Filler R, Smith DA, Golubets K, Girardi M. The contribution of Langerhans cells to cutaneous malignancy. Trends In Immunology 2010, 31: 460-466. PMID: 21071271, PMCID: PMC3753793, DOI: 10.1016/j.it.2010.10.001.Peer-Reviewed Original ResearchConceptsLangerhans cellsDendritic cellsRole of LCsIntraepidermal dendritic cellsAntigen-presenting cellsDC populationsCutaneous malignanciesImmunological organT cellsAdaptive immunitySkin cancerMalignant transformationEnvironmental exposuresUnique populationPotential roleCancerEpithelial tissuesCellsRecent studiesSkinMigratory changesMalignancyPathogenesisPopulationImmunity
2003
Selective immmunotherapy through extracorporeal photochemotherapy: yesterday, today, and tomorrow
Girardi M, Knobler R, Edelson R. Selective immmunotherapy through extracorporeal photochemotherapy: yesterday, today, and tomorrow. Hematology/Oncology Clinics Of North America 2003, 17: 1391-1403. PMID: 14710891, DOI: 10.1016/s0889-8588(03)00106-0.Peer-Reviewed Original ResearchConceptsLow side effect profileSide effect profilePotential novel strategyMechanism of actionImmunosuppressive medicationsExtracorporeal photochemotherapyEffect profileTransplant rejectionTreatment of cancerClinical recordsRole of ECPClinical studiesT cellsTreatment considerationsModern therapeuticsTreatmentNovel strategyGVHDMedicationsAutoimmunityCTCLMalignancyECPTherapyCancer
2002
Efficient Tumor Antigen Loading of Dendritic Antigen Presenting Cells by Transimmunization
Girardi M, Berger C, Hanlon D, Edelson RL. Efficient Tumor Antigen Loading of Dendritic Antigen Presenting Cells by Transimmunization. Technology In Cancer Research & Treatment 2002, 1: 65-69. PMID: 12614179, DOI: 10.1177/153303460200100109.Peer-Reviewed Original ResearchConceptsCutaneous T-cell lymphomaMalignant T cellsT cellsTumor antigen loadingAnti-tumor immunityManagement of patientsT-cell lymphomaAntigen presenting cellsDendritic cell differentiationDendritic cellsSelective immunotherapyPresenting cellsOnly FDATumor antigensCell lymphomaAntigen loadingTumor cellsKey cellular eventsTransimmunizationImmunotherapyPatientsCancerRecent findingsEfficient phagocytosisCells
2000
Postirradiation Morphea of the Breast Presentation of Two Cases and Review of the Literature
Schaffer J, Carroll C, Dvoretsky I, Huether M, Girardi M. Postirradiation Morphea of the Breast Presentation of Two Cases and Review of the Literature. Dermatology 2000, 200: 67-71. PMID: 10681621, DOI: 10.1159/000018322.Peer-Reviewed Original ResearchConceptsSupervoltage radiation therapyRadiation therapyPostirradiation morpheaBreast cancerSecond primary carcinomaSite of treatmentInfectious cellulitisResidual sclerosisConservative treatmentRecurrent carcinomaClinical presentationInflammatory componentMetastatic carcinomaPrimary carcinomaMorpheaNew casesCommon modalityMedical literatureCarcinomaTherapyPatientsCancerTreatmentPresentationYears